{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:25:27Z","timestamp":1792085127514,"version":"4.4.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/nrl.0b013e318183fdd8","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T08:13:51Z","timestamp":1231316031000},"page":"6-16","source":"Crossref","is-referenced-by-count":50,"title":["Molecular Imaging Studies in Parkinson Disease"],"prefix":"10.1097","volume":"15","author":[{"given":"Andre C.","family":"Felicio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming C.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clecio","family":"Godeiro-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz A. F.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique B.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210211","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.57.6.672","article-title":"Parkinson's disease.","volume":"57","author":"Marsden","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R2-2-20210211","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archneur.61.8.1224","article-title":"(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.","volume":"61","author":"Jennings","year":"2004","journal-title":"Arch Neurol"},{"key":"R3-2-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1631\/jzus.2005.B0022","article-title":"Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.","volume":"6","author":"Geng","year":"2005","journal-title":"J Zhejiang Univ Sci"},{"key":"R4-2-20210211","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-2-20210211","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.biocel.2004.09.009","article-title":"Dopaminergic neurons.","volume":"37","author":"Chinta","year":"2005","journal-title":"Int J Bioch Cell Biol"},{"key":"R6-2-20210211","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100031814","article-title":"Accuracy of clinical diagnosis in Parkinsonism. A prospective study.","volume":"18","author":"Rajput","year":"1991","journal-title":"Can J Neurol Sci"},{"key":"R7-2-20210211","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-2-20210211","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of Parkinsonian syndromes in a specialist movement disorder service.","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"key":"R9-2-20210211","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/snuc.2003.127303","article-title":"Imaging studies in movement disorders.","volume":"33","author":"Seibyl","year":"2003","journal-title":"Semin Nucl Med"},{"key":"R10-2-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2004.04.039","article-title":"PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences.","volume":"23","author":"Thobois","year":"2004","journal-title":"NeuroImage"},{"key":"R11-2-20210211","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/PL00007769","article-title":"SPECT and PET imaging of the dopaminergic system in Parkinson's disease.","volume":"247","author":"Brucke","year":"2000","journal-title":"J Neurol"},{"key":"R12-2-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/S1516-31802006000300014","article-title":"Parkinson's disease and dopamine transporter neuroimaging \u2013 a critical review.","volume":"124","author":"Shih","year":"2006","journal-title":"S\u00e3o Paulo Med J"},{"key":"R13-2-20210211","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mds.10571","article-title":"Dopamine Transporter: basic aspects and neuroimaging.","volume":"18","author":"Piccini","year":"2003","journal-title":"Mov Disord"},{"key":"R14-2-20210211","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.21315","article-title":"Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease? -A [(99m)Tc]-TRODAT-1 SPECT study.","volume":"22","author":"Shih","year":"2007","journal-title":"Mov Disord"},{"key":"R15-2-20210211","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s007020070077","article-title":"Measuring the progression of idiopathic Parkinson's disease with [123I] Beta-CIT SPECT.","volume":"107","author":"Staffen","year":"2000","journal-title":"J Neural Transm"},{"key":"R16-2-20210211","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.10573","article-title":"Role of Dopamine Transporter imaging in investigation of parkinsonian syndromes in routine clinical practice.","volume":"18","author":"Poewe","year":"2003","journal-title":"Mov Disord"},{"key":"R17-2-20210211","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1602\/neurorx.1.2.243","article-title":"Neuroimaging in Parkinson's disease.","volume":"1","author":"Brooks","year":"2004","journal-title":"NeuroRx"},{"key":"R18-2-20210211","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson's disease.","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"R19-2-20210211","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1468-1331.2007.01691.x","article-title":"Molecular imaging in hereditary forms of parkinsonism.","volume":"14","author":"Shih","year":"2007","journal-title":"Eur J Neurol"},{"key":"R20-2-20210211","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","article-title":"The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.","volume":"28","author":"Booij","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R21-2-20210211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0025-7753(04)74224-4","article-title":"Differential diagnosis of parkinsonism using dopamine transporters brain SPECT [Spanish].","volume":"122","author":"Lorenzo Bosquet","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"R22-2-20210211","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/jnnp.2004.045237","article-title":"How useful is [123I] beta-CIT SPECT in clinical practice?","volume":"76","author":"Eerola","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R23-2-20210211","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.mnm.0000243369.80765.24","article-title":"Discrimination between parkinsonian syndrome and essential tremor using artificial neural network classification of quantified DaTSCAN data.","volume":"27","author":"Hamilton","year":"2006","journal-title":"Nucl Med Commun"},{"key":"R24-2-20210211","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1590\/S0004-282X2006000400021","article-title":"Neuroimaging of the dopamine transporter in Parkinsons disease: first study using [99mTc]-TRODAT-1 and SPECT in Brazil.","volume":"64","author":"Shih","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"R25-2-20210211","first-page":"584","article-title":"Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.","volume":"41","author":"Mozley","year":"2000","journal-title":"J Nucl Med"},{"key":"R26-2-20210211","first-page":"584","article-title":"The optimal imaging time for [99Tcm]TRODAT-1\/SPET in normal subjects and patients with Parkinson's disease.","volume":"41","author":"Kao","year":"2001","journal-title":"Nucl Med Commun"},{"key":"R27-2-20210211","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.parkreldis.2004.04.002","article-title":"Diagnostic accuracy of [99mTc] TRODAT-1 SPECT imaging in early Parkinson's disease.","volume":"10","author":"Chou","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"R28-2-20210211","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02984583","article-title":"Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson's disease patients.","volume":"18","author":"Tsuchida","year":"2004","journal-title":"Ann Nucl Med"},{"key":"R29-2-20210211","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mds.10482","article-title":"Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.","volume":"18","author":"Benamer","year":"2003","journal-title":"Mov Disord"},{"key":"R30-2-20210211","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s007020050124","article-title":"[123I] Beta-CIT and SPECT in essential tremor and Parkinson's disease.","volume":"105","author":"Asenbaum","year":"1998","journal-title":"J Neural Transm"},{"key":"R31-2-20210211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s100720170040","article-title":"The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT.","volume":"22","author":"Antonini","year":"2001","journal-title":"Neurol Sci"},{"key":"R32-2-20210211","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00702-005-0311-7","article-title":"[(11)C]d-threo-methylphenidate PET in patients with Parkinson's disease and essential tremor.","volume":"113","author":"Breit","year":"2006","journal-title":"J Neural Transm"},{"key":"R33-2-20210211","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/01.mnm.0000243374.11260.5b","article-title":"Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.","volume":"27","author":"Marshall","year":"2006","journal-title":"Nucl Med Commun"},{"key":"R34-2-20210211","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-006-3003-9","article-title":"Vascular parkinsonism.","volume":"253","author":"Fujimoto","year":"2006","journal-title":"J Neurol"},{"key":"R35-2-20210211","first-page":"408","article-title":"Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.","volume":"42","author":"Tzen","year":"2001","journal-title":"J Nucl Med"},{"key":"R36-2-20210211","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000047611","article-title":"Parkinsonism in patients with vascular dementia: clinical, computed- and positron emission-tomographic findings.","volume":"11","author":"De Reuck","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"R37-2-20210211","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.10092","article-title":"[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.","volume":"17","author":"Gerschlager","year":"2002","journal-title":"Mov Disord"},{"key":"R38-2-20210211","first-page":"1688","article-title":"123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.","volume":"45","author":"Lorberboym","year":"2004","journal-title":"J Nucl Med"},{"key":"R39-2-20210211","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/jnnp.2006.091322","article-title":"Ten steps to identify atypical parkinsonism.","volume":"77","author":"Abdo","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R40-2-20210211","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0733-8619(05)70037-2","article-title":"Lumpling and splitting the Parkinson plus syndromes. Dementia with Lewy Bodies, Multiple System Atrophy, Progressive Supranuclear Palsy, and Cortical-Basal Ganglionic Degeneration.","volume":"19","author":"Mark","year":"2001","journal-title":"Neurol Clin"},{"key":"R41-2-20210211","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00702-005-0382-5","article-title":"Brain SPECT imaging in multiple system atrophy.","volume":"112","author":"Cilia","year":"2005","journal-title":"J Neural Transm"},{"key":"R42-2-20210211","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.410280412","article-title":"Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.","volume":"28","author":"Brooks","year":"1990","journal-title":"Ann Neurol"},{"key":"R43-2-20210211","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/jnnp.54.10.898","article-title":"Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.","volume":"54","author":"Otsuka","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R44-2-20210211","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp.57.3.278","article-title":"Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.","volume":"57","author":"Burn","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R45-2-20210211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.1265","article-title":"Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.","volume":"17","author":"Pirker","year":"2002","journal-title":"Mov Disord"},{"key":"R46-2-20210211","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0038-1623903","article-title":"[[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.","volume":"42","author":"Berding","year":"2003","journal-title":"Nuklearmedizin"},{"key":"R47-2-20210211","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","article-title":"Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.","volume":"112","author":"Plotkin","year":"2005","journal-title":"J Neural Transm"},{"key":"R48-2-20210211","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00259-004-1733-4","article-title":"Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease.","volume":"32","author":"Stoffers","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R49-2-20210211","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00259-004-1667-x","article-title":"Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.","volume":"32","author":"Swanson","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R50-2-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00415-006-3004-8","article-title":"Drug induced parkinsonism. A review.","volume":"253","author":"Hirose","year":"2006","journal-title":"J Neurol"},{"key":"R51-2-20210211","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00002512-199405020-00006","article-title":"Drug-induced parkinsonism in the aged. Recognition and prevention.","volume":"5","author":"Gershanik","year":"1994","journal-title":"Drug Aging"},{"key":"R52-2-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S0004-282X1998000200001","article-title":"Etiology of parkinsonism in a Brazilian Movement Disorders Clinic.","volume":"56","author":"Cardoso","year":"1998","journal-title":"Arq Neuropsiquiatr"},{"key":"R53-2-20210211","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1590\/S0004-282X2004000500008","article-title":"Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizina.","volume":"62","author":"Fabiani","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"R54-2-20210211","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(05)70250-7","article-title":"Drug-induced tremors.","volume":"4","author":"Morgan","year":"2005","journal-title":"Lancet Neurol"},{"key":"R55-2-20210211","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002826-199106000-00013","article-title":"Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?","volume":"14","author":"Melamed","year":"1991","journal-title":"Clin Neuropharmacol"},{"key":"R56-2-20210211","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1212\/01.WNL.0000121228.32913.00","article-title":"Reversible parkinsonism with normal Beta-CIT-SPECT in patients exposed to sodium valproate.","volume":"62","author":"Easterford","year":"2004","journal-title":"Neurology"},{"key":"R57-2-20210211","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0161-813X(03)00147-5","article-title":"Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism.","volume":"25","author":"Huang","year":"2004","journal-title":"Neurotoxicology"},{"key":"R58-2-20210211","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mds.20381","article-title":"[18F]FDOPA PET and clinical features in parkinsonism due to manganism.","volume":"20","author":"Racette","year":"2005","journal-title":"Mov Disord"},{"key":"R59-2-20210211","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov Disord"},{"key":"R60-2-20210211","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1474-4422(06)70523-3","article-title":"Psychogenic movement disorders.","volume":"5","author":"Hinson","year":"2006","journal-title":"Lancet Neurol"},{"key":"R61-2-20210211","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1017\/S0317167100003292","article-title":"Psychogenic Movement Disorders.","volume":"30","author":"Miyasaki","year":"2003","journal-title":"Can J Neurol Sci"},{"key":"R62-2-20210211","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mds.10575","article-title":"DAT imaging in drug-induced and psychogenic parkinsonism.","volume":"18","author":"Tolosa","year":"2003","journal-title":"Mov Disord"},{"key":"R63-2-20210211","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.21062","article-title":"123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism.","volume":"21","author":"Gaig","year":"2006","journal-title":"Mov Disord"},{"key":"R64-2-20210211","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/mds.20720","article-title":"Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy.","volume":"21","author":"Benaderette","year":"2006","journal-title":"Mov Disord"},{"key":"R65-2-20210211","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10072-006-0546-6","article-title":"Parkinson's disease and dementia.","volume":"27","author":"Padovani","year":"2006","journal-title":"Neurol Sci"},{"key":"R66-2-20210211","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","article-title":"Motor signs during the course of Alzheimer disease.","volume":"63","author":"Scarmeas","year":"2004","journal-title":"Neurology"},{"key":"R67-2-20210211","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0278-5846(01)80005-1","article-title":"[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.","volume":"25","author":"Okamura","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R68-2-20210211","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuroimage.2004.06.045","article-title":"The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.","volume":"23","author":"Colloby","year":"2004","journal-title":"Neuroimage"},{"key":"R69-2-20210211","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.","volume":"61","author":"O'Brien","year":"2004","journal-title":"Arch Neurol"},{"key":"R70-2-20210211","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00702-004-0140-0","article-title":"Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study.","volume":"111","author":"Ceravolo","year":"2004","journal-title":"J Neural Transm"},{"key":"R71-2-20210211","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","article-title":"Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.","volume":"62","author":"Walker","year":"2004","journal-title":"Neurology"},{"key":"R72-2-20210211","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ana.20088","article-title":"Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease.","volume":"55","author":"Gilman","year":"2004","journal-title":"Ann Neurol"},{"key":"R73-2-20210211","first-page":"276","article-title":"DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease [Spanish].","volume":"41","author":"Vaamonde-Gamo","year":"2005","journal-title":"Rev Neurol"},{"key":"R74-2-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000085070","article-title":"Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT.","volume":"20","author":"Shimizu","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R75-2-20210211","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"key":"R76-2-20210211","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.expneurol.2004.06.017","article-title":"Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.","volume":"191","author":"Gilman","year":"2005","journal-title":"Exp Neurol"},{"key":"R77-2-20210211","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clineuro.2004.12.005","article-title":"Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.","volume":"107","author":"Mito","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"R78-2-20210211","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00259-005-1830-z","article-title":"Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.","volume":"32","author":"Colloby","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R79-2-20210211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroimage.2006.07.026","article-title":"In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.","volume":"33","author":"Colloby","year":"2006","journal-title":"Neuroimage"},{"key":"R80-2-20210211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mds.10572","article-title":"Role of Dopamine Transporter SPECT for the practioner and the general neurologist.","volume":"18","author":"Oertel","year":"2003","journal-title":"Mov Disord"},{"key":"R81-2-20210211","first-page":"292","article-title":"Study of the pre and post-synaptic dopaminergic system by DaTSCAN\/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients [Spanish].","volume":"19","author":"Vaamonde","year":"2004","journal-title":"Neurologia"},{"key":"R82-2-20210211","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1590\/S1516-44462007000200003","article-title":"Can molecular imaging techniques identify biomarkers for neuropsychiatric disorders?","volume":"29","author":"Bressan","year":"2007","journal-title":"Rev Bras Psiquiatr"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00127893-200901000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:23:49Z","timestamp":1618035829000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-200901000-00002"}},"subtitle":["Reducing Diagnostic Uncertainty"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e318183fdd8","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}